Spectral Medical Inc. (TSE:EDT – Get Free Report)’s share price hit a new 52-week low on Friday . The stock traded as low as C$1.13 and last traded at C$1.15, with a volume of 268520 shares changing hands. The stock had previously closed at C$1.24.
Spectral Medical Stock Performance
The company has a debt-to-equity ratio of 26.03, a current ratio of 0.61 and a quick ratio of 0.45. The stock has a market cap of C$337.59 million, a P/E ratio of -9.58 and a beta of 0.94. The company has a fifty day moving average of C$1.34 and a 200 day moving average of C$1.36.
About Spectral Medical
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The segments of the group are Spectral Medical Inc, which is the key revenue-generating segment that manufactures and sells its EAA diagnostic and certain proprietary reagents; Dialco Medical Inc segment; and Corporate.
Further Reading
- Five stocks we like better than Spectral Medical
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
